{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:17:01Z","timestamp":1790151421238,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.euros.2022.11.024","type":"journal-article","created":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T18:17:49Z","timestamp":1672078669000},"page":"54-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Clinical Value of a Routine Urine Culture Prior to Transrectal Prostate Biopsy"],"prefix":"10.1016","volume":"48","author":[{"given":"Joakim","family":"\u00d6rtegren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wimmerstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"\u00c5berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kan","family":"Janson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Kj\u00f6lhede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Kahlmeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Bratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2022.11.024_b0005","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.eururo.2013.05.049","article-title":"Systematic review of complications of prostate biopsy","volume":"64","author":"Loeb","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2022.11.024_b0010","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1017\/S0950268815002885","article-title":"The global burden of major infectious complications following prostate biopsy","volume":"144","author":"Bennett","year":"2016","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.euros.2022.11.024_b0015","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.juro.2011.06.057","article-title":"Complications after prostate biopsy: data from SEER-Medicare","volume":"186","author":"Loeb","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2022.11.024_b0020","first-page":"97","article-title":"Infections after transrectal ultrasonic guided prostate biopsies\u2014a retrospective study","volume":"53","author":"Danielsen","year":"2019","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.euros.2022.11.024_b0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00345-019-02837-0","article-title":"Antibiotic resistance, hospitalizations, and mortality related to prostate biopsy: first report from the Norwegian Patient Registry","volume":"38","author":"Johansen","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.euros.2022.11.024_b0030","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1007\/s00345-021-03614-8","article-title":"The negative aftermath of prostate biopsy: prophylaxis, complications and antimicrobial stewardship: results of the global prevalence study of infections in urology 2010\u20132019","volume":"39","author":"Alidjanov","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.euros.2022.11.024_b0035","unstructured":"Lightner DJ, Wymer K, Sanchez J, Kavoussi L. AUA recommended antibiotic prophylaxis for urological procedures: table V. 2019 https:\/\/www.auanet.org\/documents\/Guidelines\/PDF\/Antimicrobial%20Prophylaxis%20Table%20V.pdf."},{"key":"10.1016\/j.euros.2022.11.024_b0040","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.eururo.2012.06.003","article-title":"Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study","volume":"63","author":"Wagenlehner","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2022.11.024_b0045","unstructured":"EAU. Guidelines on prostate cancer. 2019. https:\/\/uroweb.org\/wp-content\/uploads\/EAU-EANM-ESUR-ESTRO-SIOG-Guidelines-on-Prostate-Cancer-2019-1.pdf."},{"key":"10.1016\/j.euros.2022.11.024_b0050","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1097\/01.ju.0000061280.23447.29","article-title":"Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy","volume":"169","author":"Tal","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2022.11.024_b0055","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10096-009-0862-x","article-title":"Modeling antibiotic resistance to project future rates: quinolone resistance in Escherichia coli","volume":"29","author":"Durham","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.euros.2022.11.024_b0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2334-14-13","article-title":"A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance","volume":"14","author":"Bell","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.euros.2022.11.024_b0065","unstructured":"EMA. Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone and fluoroquinolone antibiotics. 2019. https:\/\/www.ema.europa.eu\/en\/documents\/press-release\/disabling-potentially-permanent-side-effects-lead-suspension-restrictions-quinolone-fluoroquinolone_en.pdf."},{"key":"10.1016\/j.euros.2022.11.024_b0070","unstructured":"EAU guidelines. Presented at the EAU Annual Congress Amsterdam; 2022."},{"key":"10.1016\/j.euros.2022.11.024_b0075","unstructured":"Bonkat G BR, Bruy\u00e8re F, Cai T, Geerlings SE, K\u00f6ves F, Schubert S, Wagenlehner F. The European Association of Urology: guidelines on urological infections. 2021. http:\/\/uroweb.org\/guidelines\/compilations-of-all-guidelines\/."},{"key":"10.1016\/j.euros.2022.11.024_b0080","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.eururo.2006.05.003","article-title":"Single-dose antibiotic prophylaxis in core prostate biopsy: impact of timing and identification of risk factors","volume":"50","author":"Lindstedt","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2022.11.024_b0085","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/pcan.2010.8","article-title":"Is urine culture routinely necessary before prostate biopsy?","volume":"13","author":"Bruy\u00e8re","year":"2010","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.euros.2022.11.024_b0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11255-017-1752-2","article-title":"Preoperative urine culture is unnecessary in asymptomatic men prior to prostate needle biopsy","volume":"50","author":"Qi","year":"2018","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.euros.2022.11.024_b0095","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.euros.2022.11.024_b0100","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/bju.13410","article-title":"Complications after prostate biopsies in men on active surveillance and its effects on receiving further biopsies in the Prostate cancer Research International: Active Surveillance (PRIAS) study","volume":"118","author":"Bokhorst","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2022.11.024_b0105","first-page":"317","article-title":"Rate and characteristics of infection after transrectal prostate biopsy: a retrospective observational study","volume":"55","author":"Forsvall","year":"2021","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.euros.2022.11.024_b0110","unstructured":"Department of Clinical Microbiology, Region Kronoberg. Resistensuteckling Kronoberg och Blekinge l\u00e4n (Swedish). 2020. https:\/\/www.mikrobiologi.org\/resistensutveckling."},{"key":"10.1016\/j.euros.2022.11.024_b0115","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00345-018-2217-7","article-title":"The effectiveness of targeted relative to empiric prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy: a meta-analysis","volume":"36","author":"Scott","year":"2018","journal-title":"World J Urol"},{"key":"10.1016\/j.euros.2022.11.024_b0120","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s11255-014-0713-2","article-title":"Reducing the risk of infection for transrectal prostate biopsy with povidone\u2013iodine: a systematic review and meta-analysis","volume":"46","author":"Pu","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.euros.2022.11.024_b0125","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/JU.0000000000001399","article-title":"Nonantibiotic strategies for the prevention of infectious complications following prostate biopsy: a systematic review and meta-analysis","volume":"205","author":"Pradere","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2022.11.024_b0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.eururo.2020.10.019","article-title":"European Association of Urology position paper on the prevention of infectious complications following prostate biopsy","volume":"79","author":"Pilatz","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2022.11.024_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/976273","article-title":"Global fluoroquinolone resistance epidemiology and implications for clinical use","volume":"2012","author":"Dalhoff","year":"2012","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"10.1016\/j.euros.2022.11.024_b0140","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/cid\/cit503","article-title":"Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans","volume":"57","author":"Colpan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.euros.2022.11.024_b0145","unstructured":"EAU. Guidelines on prostate cancer. 2021. https:\/\/uroweb.org\/guidelines\/prostate-cancer\/chapter\/diagnostic-evaluation."},{"key":"10.1016\/j.euros.2022.11.024_b0150","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.eururo.2019.06.011","article-title":"Time to adapt our practice? The European Commission has restricted the use of fluoroquinolones since March 2019","volume":"76","author":"Bonkat","year":"2019","journal-title":"Eur Urol"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168322027197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168322027197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:08:12Z","timestamp":1762978092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666168322027197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":30,"alternative-id":["S2666168322027197"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2022.11.024","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Value of a Routine Urine Culture Prior to Transrectal Prostate Biopsy","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2022.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}